These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38207176)
1. NO EFFECT OF REAL-WORLD UNIVERSAL FACE MASKING ON POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS RATE AT A SINGLE TERTIARY ACADEMIC CENTER. Haliyur R; Sinha AK; Andrews CA; Musch DC; Conrady CD; Zacks DN; Huvard MJ Retina; 2024 May; 44(5):916-922. PubMed ID: 38207176 [TBL] [Abstract][Full Text] [Related]
2. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS DURING THE COVID-19 PANDEMIC WITH IMPLEMENTATION OF UNIVERSAL MASKING. Naguib MM; Ghauri S; Mukhopadhyay A; Schefler AC Retina; 2021 Nov; 41(11):2208-2214. PubMed ID: 33958531 [TBL] [Abstract][Full Text] [Related]
3. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections. ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955 [TBL] [Abstract][Full Text] [Related]
4. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes. Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab. Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S; Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ; Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902 [TBL] [Abstract][Full Text] [Related]
7. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome. Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C; Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127 [TBL] [Abstract][Full Text] [Related]
8. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Chen E; Lin MY; Cox J; Brown DM Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800 [TBL] [Abstract][Full Text] [Related]
9. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Meredith TA; McCannel CA; Barr C; Doft BH; Peskin E; Maguire MG; Martin DF; Prenner JL; Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167 [TBL] [Abstract][Full Text] [Related]
11. Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections. Hébert M; You E; Hammamji K; Bourgault S; Caissie M; Tourville É; Dirani A Can J Ophthalmol; 2022 Dec; 57(6):364-369. PubMed ID: 34419421 [TBL] [Abstract][Full Text] [Related]
12. EFFECT OF PHYSICIAN FACE MASK USE ON POSTINJECTION ENDOPHTHALMITIS. Fortes BH; Astafurov KV; Hodge DO; Smith WM; Barkmeier AJ; Olsen TW; Iezzi R; Bakri SJ Retina; 2022 Nov; 42(11):2120-2127. PubMed ID: 35963006 [TBL] [Abstract][Full Text] [Related]
13. Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis. Torres-Costa S; Ramos D; Brandão E; Carneiro Â; Rosas V; Rocha-Sousa A; Falcão-Reis F; Falcão M Eur J Ophthalmol; 2021 Mar; 31(2):600-606. PubMed ID: 32019339 [TBL] [Abstract][Full Text] [Related]
14. The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates. VanderBeek BL; Bonaffini SG; Ma L Ophthalmology; 2015 Nov; 122(11):2311-2315.e1. PubMed ID: 26281823 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center. Modjtahedi BS; Finn AP; Barb SM; MacLachlan MJ; van Zyl T; Papakostas TD; Eliott D Ophthalmol Retina; 2019 Jan; 3(1):61-72. PubMed ID: 30929817 [TBL] [Abstract][Full Text] [Related]
16. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ; Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453 [TBL] [Abstract][Full Text] [Related]